[Anterior ischemic neuropathy associated with antiphospholipid syndrome].
Smirnova
T V
TV
Kozlovskaia
N L
NL
Kiseleva
T N
TN
Eliseeva
E G
EG
Kravchuk
E A
EA
Budzinskaia
M V
MV
Kazarian
E E
EE
D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications*; D003937:Diagnosis, Differential; D005260:Female; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008875:Middle Aged; D009902:Optic Neuritis / Q000175:diagnosis; D018917:Optic Neuropathy, Ischemic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use; D014792:Visual Acuity
D000925:Anticoagulants; D000975:Antioxidants; D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents